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OBJECTIVE: Unplanned excision of soft tissue sarcomas is common because benign soft tissue lesions are very
frequent. This study evaluated the impact of unplanned resections on overall survival, local recurrence and
distant metastasis in patients with soft tissue sarcomas of the extremities.
METHODS: In total, 52 patients who were diagnosed with soft tissue sarcomas between May 2001 and March
2011 were analyzed in a retrospective study. Of these patients, 29 (55.8%) had not undergone previous
treatment and the remaining 23 (44.2%) patients had undergone prior resection of the tumor without
oncological planning. All subsequent surgical procedures were performed at the same cancer referral center.
The follow-up ranged from 6 to 122 months, with a mean of 39.89 months. Age, lesion size and depth,
histological grade, surgical margins, overall survival, local and distant recurrence and adjuvant therapies were
compared.
RESULTS: Residual disease was observed in 91.3% of the re-resected specimens in the unplanned excision
group, which exhibited greater numbers of superficial lesions, low histological grades and contaminated
surgical margins compared with the re-resected specimens in the planned excision group. No differences were
observed in local recurrence and 5-year overall survival between the groups, but distant metastases were
significantly associated with planned excision after adjustment for the variables.
CONCLUSIONS: There was no difference between patients undergoing unplanned excision and planned
excision regarding local recurrence and overall survival. The planned excision group had a higher risk of distant
metastasis, whereas there was a high rate of residual cancer in the unplanned excision group.
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& INTRODUCTION
Soft tissue sarcomas (STSs) are rare primary malignant
neoplasms that originate from the mesoderm and account
for less than 1% of all malignant tumors. STSs may appear at
any age and with virtually any localization (1-3) but
predominantly occur in the extremities (in approximately
two-thirds of cases) (3). According to the World Health
Organization (WHO), the incidence of STSs is 30 cases per
million people per year (4). Most STSs have no clearly
defined etiology, but multiple associated and predisposing
factors, such as genetic mutations in pluripotent mesench-
ymal stem cells and exposure to radiation and certain
herbicides, have been described (3,4).
The ability of surgeons and radiotherapists to accurately
assess the extent of the disease from clinical examinations and
images, and especially magnetic resonance imaging (MRI) has
improved local control of the disease in 95% of cases (8,9).
Prompt diagnosis and treatment at an oncology center using
biopsies, planned wide resections and adjuvant therapy have
increased the 5-year survival rate from 62% to 84% (2,10-12).
Certain STSs are inadvertently and inappropriately
resected prior to correct diagnosis following an anatomo-
pathologic examination because although STSs are rare,
benign tumors are very common in soft tissues (3,000 new
cases per million per year, compared with 30 cases of STSs)
(4). Oversight in STS management is associated with the
inexperience of surgeons at non-oncology institutions (2,13).
Copyright  2014 CLINICS – This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.
No potential conflict of interest was reported.
DOI: 10.6061/clinics/2014(09)01
CLINICAL SCIENCE
579
Giuliano and Eilber (7) introduced the term ‘‘unplanned
total excision’’ for the macroscopic removal of STSs without
consideration of preoperative images or the surgical
margins of the normal tissue around the tumors. Noria
et al. (11) further described this term with respect to STS as
unplanned resection of a lesion without taking advantage of
the benefits of preoperative diagnostic modalities and
without the intention to achieve tumor-free margins.
Unplanned excision (Unpex) of STSs occurs often, but the
negative effects of this manipulation on definitive local and
systemic treatments and prognosis remain controversial
(14). The prognostic factors for Unpex are not as well
defined as the prognostic factors for STSs that are removed
exclusively at oncology centers. The prognostic factors for
patient survival in STS cases include clinical stage,
histological grade and subtype, size, depth, metastasis at
diagnosis and the location of the primary disease. These
factors differ from the most important factors in local
disease control: surgical margins and adjuvant radiotherapy
(5,14).
The objective of this study was to evaluate the impact of
these unplanned resections on overall survival, local
recurrence and distant metastasis in patients with STSs of
the extremities.
& MATERIALS AND METHODS
The records of patients who were treated at the Orthopedic
Oncology Service of Hospital de Clı´nicas of the University of
Campinas (HC-UNICAMP) were assessed. Only patients
over 14 years old who had a diagnosis of an STS in the
extremities and who were initially treated at another
institution or directly referred to HC-UNICAMP for initial
treatment from May 2001 to March 2011 were included.
Patients without neoplasms in the extremities (e.g., the head,
neck, trunk or retroperitoneum) and patients who had not
undergone definitive surgical treatment were excluded. The
Institutional Review Board of the Faculty of Medical Sciences
of UNICAMP (FCM-UNICAMP) approved this study.
A total of 52 patients with STSs (Table 1), comprising 30
(57.7%) males and 23 (42.3%) females with a mean age of
44.96¡17.23 years (16.92 to 80.69) at admission, were
included. Of these patients, 29 (55.8%) have undergone
surgeries exclusively at our center (i.e., planned surgeries
(Pex)). The remaining 23 (44.2%) patients had undergone
prior unplanned resection (Unpex) and were treated with
definitive planned resection at our center.
The patients were divided into high- and low-grade
sarcoma groups based on histological grade, which was
determined by a single specialist in musculoskeletal tumors
in the Department of Anatomopathology at FCM-
UNICAMP using a three-level scale: grade I was considered
as low grade, and grades II and III were considered as high
grade (3).
Lesion size was assessed by MRI or specimen resection
using the larger diameter or axis as a reference.
Sarcoma depths were divided into superficial (above the
muscle fascia) and deep (below the muscle fascia) lesions.
The surgical margins of the specimens resected during
definitive surgery were divided into groups based on
Enneking’s classification (15,16): 1. a positive margin with
the presence of neoplasms at any portion of the borders
previously marked, 2. a negative margin with neoplasms
less than 10 mm from the edges of the resection, and 3. a
negative margin with neoplasms at a distance equal to or
greater than 10 mm from the edges of the resection.
The rate of residual disease (i.e., the presence of viable
neoplasms) was evaluated for the re-resected specimens
from the Unpex group.
Amputations or disarticulations and complications after
definitive surgery, chemotherapy and radiotherapy were
assessed in both groups. Local recurrence was verified after
definitive surgery using clinical examinations and MRI
during the follow-up exams. Distant metastases were
identified using computed tomography examinations and/
or bone scintigraphy. The overall survival time was
measured from the date of patient admission to patient
death. Patients who left prior to the end of the 5-year follow-
up were punctually censored on 5-year survival curves.
Statistical analyses were performed. Categorical variables
were analyzed using frequency tables and quantitative
variables were analyzed using descriptive measures (e.g.,
the mean and standard deviation). Chi-squared association
tests (e.g., Fisher’s exact test and Pearson’s Chi-square test)
were used for bivariate analyses. Multivariate analyses were
performed using Cox multivariate and logistic regression,
with a confidence interval (CI) of 95%. An analysis of
survival was performed using Kaplan-Meier curves. A
value of p,0.05 was considered to be statistically significant.
& RESULTS
The distribution of histological STS subtypes revealed
synovial sarcoma in 11 patients (21.2%) and liposarcoma,
Table 1 - Descriptive statistics.
Variable N %
Gender
Female 22 42.3%
Male 30 57.7%
Mean age (years) 44.96¡17.23
Follow-up (months) 39.9¡29.3
Type of resection
Planned 29 55.8%
Unplanned 23 44.2%
Histological grade
Low 4 7.7%
High 48 92.3%
Size
,5 cm 6 11.5%
$5 cm 46 88.5%
Depth
Superficial 5 9.6%
Deep 47 90.4%
Surgical margins
Positive 5 9.6%
Negative, ,10 mm 18 34.6%
Negative, $10 mm 29 55.80%
Radiotherapy 29 55.7%
Chemotherapy 33 63.4%
Amputations/disarticulations 21 40.4%
Postoperative complications 10 19.2%
Soft tissue reconstruction 2 4%
Positivity for residual disease
(Unpex group)
21 91.3%
Local recurrence (months) 4 (14.4¡4.7) 7.7%
Distant metastases (months) 23 (10 at admission) 44.2%
(13 after admission
14.4¡10.5)
Death (months) 10 (31¡3.8) 19.2%
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malignant fibrous histiocytoma and myxofibrosarcoma in
six patients each (11.5%) (Table 2).
The majority (92.3%) of lesions were high grade. The
remaining 7.7% of lesions were classified as low grade and
these lesions were only identified in patients in the Unpex
group.
Among all sarcomas, 11.5% were smaller than 5 cm and
88.5% were greater than or equal to 5 cm.
Deep sarcomas represented the majority (90.4%) of cases.
Among superficial STSs, four were in the Unpex group and
only one was in the Pex group.
In addition, the surgical margins of the definitive surgical
resection specimens revealed positive margins in five
patients (9.6%), negative margins of less than 10 mm in 18
patients (34.6%) and negative margins greater than or equal
to 10 mm in 29 patients (62% and 55.80%, respectively).
Eighteen (62%) of these last 29 patients with negative
margins had undergone amputations or disarticulations.
Radiotherapy treatment was prescribed for 29 (55.7%) of
52 patients in the study, regardless of the size (p= 0.39),
histological grade (p= 0.06) or depth (p= 0.64) of the lesion;
the condition of the surgical margins (p= 0.06); or the
incidence of local recurrence (p= 0.12).
Chemotherapy was initiated in 33 patients (63.4%) in the
sample. This therapy was prescribed significantly more
often for STSs that were greater than or equal to 5 cm
(p= 0.02), high grade (p= 0.01) and deep (p= 0.01) and that
had distant metastases (p= 0.01).
In total, 21 patients underwent amputation or disarticula-
tion procedures in this study (40.4%), with 13 (44.8%) in the
Pex group and eight (34.8%) in the Unpex group.
Among the 10 patients diagnosed with postoperative
complications (19.2%), we found five cases of infection (9.6%
of the subjects), two cases of phantom pain after amputa-
tion, one case of dehiscence of the surgical wound and two
cases of pathologic fracture. One fracture occurred after
radiotherapy, without evidence of recurrent neoplasms and
the other occurred during local recurrence.
Two patients (4%), both of whom belonged to the Unpex
group, underwent procedures for the reconstruction of soft
tissue due to inappropriate coverage of the surgical wound.
We analyzed the rate of residual disease as part of re-
resection, such as the expansion of surgical margins and
positivity was found in 91.3% of patients (21/23). Of the 23
patients in the Unpex group, only four arrived without
apparent disease, based on either physical examination or
imaging at baseline at HC-UNICAMP. After undergoing
margin expansion, two of these four patients had residual
disease upon pathologic evaluation.
Pex compared with unpex
The Pex and Unpex groups did not differ in gender, age at
admission, length of follow-up, lesion size, radiotherapy,
chemotherapy, amputation, postoperative complications,
soft tissue reconstruction procedures, local recurrence,
distant metastasis or death (Table 3). The Unpex group had
a higher proportion of superficial sarcomas (p= 0.013), low
histological grades (p= 0.033) and positive margins after re-
resection at HC-UNICAMP (p= 0.034) compared with the Pex
group. Survival curves were calculated using 5-year Kaplan-
Meier analysis with a Cox model and they showed no
difference for local recurrence-free survival (96.5% versus
86.2% for Pex versus Unpex, respectively; p= 0.31), metasta-
sis-free survival (51.9% versus 74.9% for Pex versus Unpex,
respectively; p= 0.07) or overall survival (46.1% versus 82.7%
for Pex versus Unpex, respectively; p= 0.16) (Figures 1 to 3). In
the multivariate analysis, the occurrence of local recurrence
(p= 0.17) and death (p= 0.17) remained not significantly
different between the groups. However, after performing
the multivariate analysis, we verified that patients under-
going Pex had an 8.17 times higher risk of developing distant
metastases compared with the Unpex group (p= 0.03).
Local recurrence
Four (7.7%) local relapses were observed: three in the
Unpex group and one in the Pex group (Table 1). The mean
Table 2 - Histological type.
Synovial sarcoma 11(21%)
Liposarcoma 6(11%)
Malignant fibrous histiocytoma 6(11%)
Myxofibrosarcoma 6(11%)
Clear-cell sarcoma 4(8%)
Malignant schwannoma 3(6%)
Rhabdomyosarcoma 3(6%)
Dermatofibrosarcoma protuberans 3(6%)
Chondrosarcoma 2(4%)
Leiomyosarcoma 2(4%)
Pleomorphic sarcoma 2(4%)
Fibrosarcoma 1(2%)
Alveolar Sarcoma 1(2%)
Soft tissue Ewing sarcoma/PNET 1(2%)
Fibromyxoid sarcoma/Evans 1(2%)
Table 3 - Comparison between planned and unplanned
resections.
Variables Pex Unpex p
Gender
Female 13 (44.8%) 9 (39.1%) 0.449
Male 16 (55.2%) 14 (60.9%)
Age
,50 years 18 (62.1%) 15 (65.2%) 0.523
$50 years 11 (37.9%) 8 (34.8%)
Follow-up
, 40 weeks 21 (72.4%) 14 (60.9%) 0.279
$ 40 weeks 8 (27.6%) 9 (39.1%)
Size
,5 cm 3 (10.3%) 3 (13.0%) 1.00
$5 cm 26 (89.7%) 20 (87.0%)
Depth
Superficial 0 5 (21.7%) 0.013*
Deep 29 (100.0%) 18 (78.3%)
Histological grade
Low 0 4 (17.4%) 0.033*
High 29 (100.0%) 19 (82.6%)
Surgical margins (definitive)
Positive 1 (3.4%) 4 (17.4%) 0.034*
Negative, ,10 mm 14 (48.3%) 4 (17.4%)
Negative, $10 mm 14 (48.3%) 15 (65.2%)
Radiotherapy 18 (62%) 11 (47.8%) 0.4
Chemotherapy 21 (72.4%) 12 (52.1%) 0.16
Amputations/disarticulations 13 (44.8%) 8 (34.8%) 0.57
Postoperative complications 5 (17%) 5 (21.7%) 0.47
Soft tissue reconstruction 0 2 (8.7%) 0.19
Local recurrence 1 (3.4%) 3 (13%) 0.750
Distant metastases 15 (51.7%) 8 (34.8%) 0.772
Death 7 (24.1%) 3 (13%) 0.667
*p,0.05, indicating that the test result confirms a statistically valid
association between the tested variables.
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time to the onset of local recurrence was 14.4¡4.7 months
after definitive surgery performed at HC-UNICAMP. Five-
year recurrence-free survival was determined based on the
Kaplan-Meier survival curve and was 91.2%. The bivariate
analysis revealed no relationship between local recurrence
and size (p= 0.548), depth (p= 0.794), histological grade
(p= 0.835), the presence of residual lesions (p= 0.203),
surgical margins (p= 0.224), radiotherapy (p= 0.089) or
chemotherapy (p= 0.096). The multivariate analyses also
did not show any differences.
Distant metastasis
Ten patients (19.2%), six in the Pex group and four in the
Unpex group, had metastases at admission. Moreover, 13
patients, 9 in the Pex group and 4 in the Unpex group,
exhibited metastases at the follow-up (25% of all patients
and 31% of non-metastatic patients at admission). The
average time to the development of metastasis after
admission was 10.5¡14.4 months. Therefore, 23 patients
(44.2%) were diagnosed with distant metastases during the
follow-up. Distant metastasis-free survival over 5 years,
obtained from the Kaplan-Meier curve, was 62.7%. The
bivariate analysis revealed that sarcoma depth and a size
greater than 5 cm were prognostic factors that increased the
risk of distant metastases (p,0.05). Histological grade,
residual tumor and surgical margins were not related to
the incidence of distant metastases. In the multivariate
analysis, in which all variables were adjusted for positive
margins (p= 0.02) and the implementation of Pex (p= 0.03)
were significantly associated with the appearance of distant
lesions, with odds ratios of 115.58 and 8.17, respectively.
Death
Ten deaths occurred during the follow-up period,
comprising three patients in the Unpex group and seven
patients in the Pex group, with an average time to the
occurrence of the event of 31¡3.8 months. The global 5-year
survival calculated from the Kaplan-Meier curve was 65.5%.
Sarcoma size, depth, histological grade and residual
tumor were not related to death. Positive surgical margins
(p= 0.009) and the presence of distant metastasis (p= 0.001)
appeared to be significant variables in the occurrence of
death in the bivariate analysis. In the multivariate analysis, a
high histological grade (p= 0.01) and positive margins
(p= 0.01) were identified as independent prognostic factors
for the occurrence of death, with odds ratios greater than
1000 and 383.75, respectively.
& DISCUSSION
STSs continue to be inappropriately resected due to the
rarity of this disease and the lack of experience of surgeons
who work outside cancer centers, leading to high rates of
residual disease. We also believe that the clinical problems
associated with unplanned resection of a sarcoma are
applicable to surgical procedures without consideration of
potential malignancy, such as transverse skin incisions,
excessive postoperative hematomas, insults to uninvolved
joints, drainage away from a skin incision and broad
mattress skin sutures (17).
Figure 1 - Kaplan-Meier analysis of 5-year survival free of local
recurrence comparing Pex (---) with Unpex (—). Pex:
96.5%6Unpex: 86.2% (p=0.31).
Figure 2 - Kaplan-Meier analysis of 5-year survival free of distant
metastases comparing Pex (---) with Unpex (—). Pex:
51.9%6Unpex: 74.9% (p=0.07).
Figure 3 - Kaplan-Meier analysis of 5-year overall survival
comparing Pex (---) with Unpex (—). Pex: 46.1%6 Unpex:
82.7% (p=0.16).
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First, we analyzed the entire group (52 patients) to
identify prognostic factors for the development of local
recurrence, distant metastasis and death.
Local recurrence occurred in only four patients (7.7%) in
this study, similar to the 4.1% observed by Novais et al. (18)
and the 13% reported by Lewis et al. (19). Local recurrence
was not associated with any of the studied variables, in
contrast to published data, which showed that surgical
margins and radiotherapy affect local tumor recurrence
(6,14,20,21,22,23).
Excluding the patients with metastasis at the beginning of
this study, the rate of distant metastasis was 31% (13/42),
similar to the 32.1% found by Novais et al. (18) and above
the 18% and 22% reported by Lewis et al. (19) and Pisters
et al. (21), respectively. After adjusting the data through
multivariate analysis, affected surgical margins (p= 0.02)
and planned resection (p= 0.03) were considered to be
unfavorable prognostic factors for the occurrence of distant
metastases. Regarding positive surgical margins, what was
observed in this study is not consistent with the data of
Novais et al. (18) but agrees with the analysis of 2,084 STSs
in adults conducted by Stojadinovic et al. (25). In this group,
lesions that were larger than 5 cm, high grade or deep did
not correlate with distant metastasis, as described by Lewis
et al. (19).
The present study revealed that 44.2% of the patients
treated for STSs at this oncology center underwent Unpex,
which is within the range of 18% to 64.6% found in the
literature (1,2,6,9,11,14,26-28).
When comparing the groups, the Pex group showed a
higher frequency of superficial lesions. By comparing
subcutaneous STSs with deep STSs, Peabody et al. (30)
showed that 94% of patients with superficial lesions had
surgery prior to treatment at a referral center, whereas only
approximately half (52%) of patients with deep lesions were
operated on outside of the sarcoma center. Based on these
findings, we can assume that superficial lesions are less
challenging than deeply located lesions are for surgeons
who are willing to operate on soft tissue tumors without
oncological planning and to treat synovial cysts. However,
Umer et al. (24) found no significant difference between the
baseline characteristics of these two groups.
A significant difference was also found in the Unpex
group, with a greater presence of positive margins and
expected re-manipulation due to major technical difficulties,
such as difficulty in differentiating neoplastic tissue
scarring. These findings are in contrast to the results
reported by Fiore et al. (26). These researchers showed a
higher incidence of positive surgical margins in their Pex
group (p,0.001). A plausible hypothesis justifying this
significant predominance of positive margins in the Pex
group in the study by Fiore et al. (26) is that the anatomical
location of an STS in relation to the neurovascular bundle or
adjacent bone hinders the achievement of adequate margins.
There was no difference in amputations or disarticula-
tions between the Pex and the Unpex groups, similar to the
observation by Teixeira et al. (31) in a total of 30 cases of
STSs. Only two cases (13.3% of non-amputees) belonged to
the Unpex group, in contrast to the findings of Arai et al.
(32), who reported 47% with grafts or flaps in the Pex group
compared with 71% in the Unpex group (p= 0.002).
The presence of residual disease in patients re-operated
on after Unpex was demonstrated in 21 of 23 specimens
(91.3%). Studies that excluded obvious local recurrence
upon physical examination and imaging studies from their
samples reported a percentage of residual tumor ranging
from 35% to 59% (1,2,11,25). Authors who evaluated every
case of Unpex, regardless of the presence of local disease,
showed a residual disease rate varying from 23.6% to 91%
(7,9,14,26,28), designating our study as one with a higher
rate of residual tumor after Unpex and showing the
ineffectiveness of unplanned pretreatment. The local recur-
rence rate in patients undergoing Unpex ranges from 5% to
34% in the literature (1,2,14) and the present study is within
this range for the three cases diagnosed during follow-up
(13%). In this sample, no difference was found between the
Pex and the Unpex groups in local tumor recurrence
(p= 0.17), as reported by Teixeira et al. (31), Arai et al.
(32), Lewis et al. (28) and others (6,26). In contrast, Potter
et al. (14) showed that those patients undergoing Unpex had
a 34% recurrence rate, compared with only 6% of patients
undergoing Pex (p,0.0001), even after extensive resection of
the tumor and radiation in two-thirds of cases.
Unexpectedly, after adjustment for other variables, the
group that underwent Pex showed a greater risk of distant
lesions (p= 0.03), with an odds ratio of 8.17 (95% CI: 0.81 to
29), and was approximately eight times more likely to
develop distant metastases compared with the Unpex
group. Similar results were obtained by Lewis et al. (28),
with survival without distant metastasis of 83% for Unpex
and only 63% for Pex and p= 0.005 after adjustment for
other risk factors. Arai et al. (32), Qureshi et al. (33) and
Fiore et al. (26) showed no differences in the occurrence of
distant metastases with respect to the variable ‘‘planned
resection.’’ There was no relationship between distant
metastasis and local recurrence (p= 0.088) during follow-
up, as reported by Gustafson et al. (29).
For Lewis et al. (28), whose study included a total of 1,092
individuals and was conducted at MSKCC, those patients
who underwent Pex (70%) showed worse 5-year survival
than did the Unpex group (88%) (p= 0.005), suggesting that
re-resection, or margin amplification, is a predictor of
improved survival and the occurrence of distant metastases.
Possible explanations, according to Lewis et al. (28), are as
follows: a) the re-resection or expansion of the resection
margins removes residual tumor that extends beyond the
primary tumor and pseudocapsule, which obviously would
not be noted by the pathologist in the specimen initially
resected during Pex; b) complete removal of the tumor site
during Pex means a loss of inhibition of satellite lesions and
subsequent diagnosis of metastasis; and c) Unpex promotes
immunity, with marked activation of dendritic cells, which
recognize antigens in the residual tumor, resulting in an
immune response with long-term memory and protecting
patients from future local recurrence and distant metastasis.
The results of this study may have been affected by a
certain bias due to the small sample size, as observed in the
descriptive statistics and the wide CIs obtained in the
multivariate analysis.
Unplanned surgical procedures for the treatment of STSs
in limbs are related to superficial, low-grade tumors and
even after expansion of the surgical margins, these
procedures show a higher frequency of positive surgical
margins. There was no difference between the patients
undergoing Unpex and Pex with respect to local recurrence
and 5-year overall survival. The Pex group had a higher risk
of distant metastasis in this series, whereas the Unpex group
had a high rate of residual cancer.
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